Navigation Links
Trevena Granted Key Composition of Matter Patent for TRV027 in U.S.
Date:7/17/2013

a Phase 2a study on the hemodynamic effects of TRV027 in patients with advanced heart failure with reduced ejection fraction (NCT01187836), as a poster at the American College of Cardiology meeting in March 2013. The Phase 2a trial was an ascending dose titration study in patients with stable NYHA Class 3 or 4 heart failure.   

About ADHF
The American Heart Association estimates that ADHF hospitalization costs the U.S. healthcare system more than $20 billion each year in direct spending.  ADHF is already the leading reason for hospitalization of individuals over 65 years old in the United States, with more than 1 million hospital admissions per year.  ADHF is also the most costly diagnosis for Medicare in the nation.  Despite the significance of this problem, current therapies are not producing meaningful improvements in patient outcomes.  ADHF incidence is increasing globally, and both heart failure mortality and hospital re-admission following an ADHF event remain extremely high.

About Trevena
Trevena, Inc. is a clinical stage pharmaceutical company focused on discovering and developing the next generation of GPCR targeted medicines.  GPCRs are the targets for at least one-third of modern medicinal products, and remain the predominant class of targets under clinical evaluation.  Trevena's expertise lies in engineering "biased ligands" that activate only the beneficial signaling pathways downstream of a GPCR to unlock new biology and avoid drug adverse effects.  In addition to TRV027, Trevena's pipeline currently includes a clinical stage mu-opioid biased ligand for post-operative pain, and earlier-stage programs for chronic pain, and Parkinson's disease.  For more details, visit www.Treve
'/>"/>

SOURCE Trevena, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Trevena, Inc. and Forest Laboratories Announce a Collaborative Agreement For Development of TRV027 for the Treatment of Acute Heart Failure
2. Trevena, Inc. to Present at the 12th Annual Needham Healthcare Conference
3. CorMedix Granted Extension of NYSE MKT Listing
4. QRxPharma Granted US Patent On Hybrid Opioids
5. Mapi Pharma Granted United States Patent Covering Glatiramer Depot for Multiple Sclerosis
6. Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review
7. Bayers Investigational Riociguat Granted U.S. FDA Priority Review for Pulmonary Arterial Hypertension and Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
8. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
9. Cedarburg Hauser Granted DEA Registration for Denver Manufacturing Facility
10. KAHR Medical Granted U.S. Patent Approval for One of its Lead Products in Development, KAHR-101
11. US Patent Granted to RBC Life Sciences for Supplement that Supports Cognitive Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 2015  New York College of Health Professions announces ... portfolio with U.S. Patent #8,996,098 donated by its Chairman ... a surgical instrument that allows surgeons to view and ... in the traditional format of a slide that is ... during surgery, thus providing the surgeon real time analysis ...
(Date:4/1/2015)... ASPEN, Colo. , April 1, 2015  Astellas ... (CKF), is pleased to sponsor the second annual Bounce ... award, which will recognize two transplant recipients who exhibit ... a career accomplishment, participation in a sport or hobby, ... loved ones. "The Bounce Back Award ...
(Date:4/1/2015)... 2015  The fairness of the proposed acquisition of ... Pharmaceutical Industries ("Teva") is being investigated by WeissLaw LLP, ... investigation focuses on possible breaches of fiduciary duty and ... of ASPX for agreeing to sell the Company to ... definitive agreement for Teva to acquire ASPX in a ...
Breaking Medicine Technology:Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 2Astellas Teams Up with The Chris Klug Foundation on the Bounce Back Award to Recognize Extraordinary Transplant Recipients 3WeissLaw LLP: Auspex Pharmaceuticals Inc. Acquisition By Teva Pharmaceutical Industries May Not Be In The Best Interest of ASPX Shareholders 2
... Recent Highlights: Qutenza ® (capsaicin) ... adoption by large US institutions; 238 hospitals purchased as of 4Q10, ... Q4 2010 revenue totaled $2.3 million including $0.5 million U.S. Qutenza ... in 17 countries at December 31, 2010 NGX-1998 Phase 2 ...
... March 30, 2011 Rochester Medical Corporation (Nasdaq: ... BioSciences N.V. today approved the previously announced sale of ... subsidiary to Rochester Medical Corporation. Rochester Medical ... and under the terms of the Share Purchase Agreement ...
Cached Medicine Technology:NeurogesX Reports Fourth Quarter and Year-End 2010 Results 2NeurogesX Reports Fourth Quarter and Year-End 2010 Results 3NeurogesX Reports Fourth Quarter and Year-End 2010 Results 4NeurogesX Reports Fourth Quarter and Year-End 2010 Results 5NeurogesX Reports Fourth Quarter and Year-End 2010 Results 6NeurogesX Reports Fourth Quarter and Year-End 2010 Results 7NeurogesX Reports Fourth Quarter and Year-End 2010 Results 8NeurogesX Reports Fourth Quarter and Year-End 2010 Results 9Fornix Shareholders Approve the Sale of Laprolan B.V. to Rochester Medical Corporation 2
(Date:4/1/2015)... April 01, 2015 New Jersey ... by other First Spouses from across the country ... March 21, 2015, World Down Syndrome Day(WDSD), to ... rapidly advancing area of Down syndrome cognition research. ... included Alabama, Alaska, American Samoa, Arizona, California, Colorado, ...
(Date:4/1/2015)... BioPlus Specialty Pharmacy (BioPlus), one ... a new app to keep health care providers informed ... C virus (HCV) infection. This ‘HCV Treatment Path’ app ... American Association for the Study of Liver Diseases (AASLD) ... oral medications to treat HCV have been approved by ...
(Date:4/1/2015)... 2015 Dr Roz Kamani, a Vancouver ... now offering her patients an opportunity to learn more ... in “Beauty Days”, which is an exclusive VIP event ... Kitsilano Skin Care Clinic. It is attended by Dr ... the latest products and services that are on offer. ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 South Florida’s ... Provisional Certificate of Authority (PCOA) approval from the State ... in the ongoing development of a retirement community that ... health, wellness and spiritual development. , America’s aging population ... meet the housing needs of seniors, according to a ...
(Date:4/1/2015)... PA (PRWEB) April 01, 2015 Health ... company and a subsidiary of West Corporation, today launched ... at http://blog.healthadvocate.com and through the Health Advocate ... healthcare consumers get, and stay, healthy. , “We’re pleased ... available to the public,” said Martin Rosen, Executive Vice ...
Breaking Medicine News(10 mins):Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2Health News:BioPlus Specialty Pharmacy Releases ‘HCV Treatment Path’ App for Hepatitis C Providers 2Health News:Dr Roz Kamani Now Offers Patients The Opportunity to Learn About Latest Products and Services 2Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:Health Advocate Launches New Health and Wellness Blog 2
... HMSY ) today announced that it will present at the William ... held June 9 - 11 at The Four Seasons Hotel in ... 10th at 4:00 p.m. CT. , , HMS Holdings ... integrity services for government healthcare programs. The Company,s clients include health ...
... 8, 2009 Ontario children are more likely to get ... of the Institute for Clinical Evaluative Sciences (ICES) has found ... of diabetes in Ontario children from 1994 to 2004. ... major health problems. Most children with diabetes have Type 1, ...
... study finds , MONDAY, June 8 (HealthDay News) -- ... the world,s most influential medical journals, a new study ... learning all they can about gender differences in response ... 661 prospective studies about types of cancer that afflict ...
... and Accountability in Kidney Care, to reduce mortality by 20 ... , , WASHINGTON, June 8 Kidney ... campaign pledging to reduce mortality among first-year dialysis patients -- ... the end of 2012. , , The ...
... , , Aspirin a Day, Other Services Cited ... WASHINGTON, June 8 As Congress tackles health reform, a new ... saved every year by investing in five basic preventive services. That ... who could benefit were advised by their doctors to take a ...
... and Rochester , ... According to New Reports from HealthLeaders-InterStudy , , ... managed care market intelligence, reports that medical home pilot initiatives ... determine whether such programs can save money by directing care ...
Cached Medicine News:Health News:Still Too Few Women in Cancer Trials 2Health News:Still Too Few Women in Cancer Trials 3Health News:Kidney Care Partners Launches Health Care Campaign to Improve Survival Rates of First-Year Dialysis Patients 2Health News:Kidney Care Partners Launches Health Care Campaign to Improve Survival Rates of First-Year Dialysis Patients 3Health News:U.S. Could Save 100,000 Lives a Year with Five Basic Preventive Services 2Health News:Medical Home Pilot Initiatives Continue to Expand Nationwide 2Health News:Medical Home Pilot Initiatives Continue to Expand Nationwide 3
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: